Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Percutaneous ethanol injection therapy

Koda, M., Murawaki, Y., Mitsuda, A., Ohyama, K., Horie, Y., Suou, T., Kawasaki, H., Ikawa, S. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000 88 529-537... [Pg.804]

Kato T, Saito Y, Niwa M, Ishiguro J, Ogoshi K. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for imresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 1994 33(Suppl) S115-18. [Pg.1286]

Seki T, Wakabayashi M, Nakagawa T, Imamura M, Tamai T, Nishimura A, Yamashiki N, Okamura A, Inoue K. Hepatic infarction following percutaneous ethanol injection therapy for hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1998 10(11) 915-18. [Pg.1286]

Sella A et al. (1992) Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer. J Urol 147 573 577 Shiina S et al. (1993) Percutaneous ethanol injection therapy for hepatocellular carcinoma resuhs in 146 patients. AJR Am J Roentgenol 160 1023 1028 Simonetti RG et al. (1991) Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 36 962-972... [Pg.223]

Eencioni R, Pinto F, ArmillottaN, Bassi AM, Moretti M, Di Giulio M, Marchi S, Uliana M, Della Capanna S, Lencioni M, Bartolozzi C (1997) Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis a European experience. Eur Radiol 7 514-519... [Pg.98]

Kirchhoff T, Chavan A, Galanski M (1998) Transarterial chemoembolization and percutaneous ethanol injection therapy in patients with hepatocellular carcinoma [comment]. Eur J Gastroenterol Hepatol 10 907-909 Kitamoto M, Imagawa M, Yamada H et al (2003) Radiofrequency ablation in the treatment of small hepatocellular carcinomas comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 181 997-1003... [Pg.120]

Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M (2002) Nonsurgical treatment of hepatocellular carcinoma from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62 64-68 Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation principles and applications. Radiographics 25 [Suppl 1] S69-S83... [Pg.121]

Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y, Terano A, Sugi-moto T (1991) Percutaneous ethanol injection therapy for hepatocellular carcinoma a histopathologic study. Cancer 68 1524-1530... [Pg.128]

Tateishi H, Oi H, Masuda N et al (1997) Appraisal of combination treatment for hepatocellular carcinoma longterm follow-up and lipiodol-percutaneous ethanol injection therapy. Semin Oncol 24 S6-81-S86-90... [Pg.242]

Yamamoto J, Okada S, Shimada K, et al (2001) Treatment strategy for small hepatocellular carcinoma comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology... [Pg.336]

The current methods for treating hepatocellular carcinoma are hepatec-tomy (Minagawa and Makuuchi, 2006),percutaneous ethanol injection therapy (PEIT) (Kumada et al., 1992 Jang et al., 2004 Koiwa et al., 2007), transcatheter... [Pg.275]

Koiwa F, Kakuta T, Tanaka R, Yumita S. 2007. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid giands in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dialysis Transplant 22 522-528. [Pg.290]

Okada, S., Aoki, K., Okazaki, N., Nose, H., Yoshimori, M., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Takayasu, K., Moriyama, N. Liver abscess after percutaneous ethanol injection (PEI) therapy for hepatocellular carcinoma. A case report. Hepato-... [Pg.518]

Huo TI, Huang YH, Wu JC, Lee PC, Chang FY, Lee SD. Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy. Scand J Gastroenterol 2002 37(3) 350-5. [Pg.1286]

Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H (2001) Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma a randomized control study. Cancer 92 1516-1524... [Pg.128]

Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Miyauchi Y, Himoto T, Kimura Y, Nakai S, Deguchi A, Yoneyama H, Yoshida S, Kuriyama S (2005) Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 11 1426-1432... [Pg.128]

Omata M, Tateishi R, Yoshida H, Shiina S (2004) Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods ethanol injection therapy and radiofrequency ablation. Gastroenterology 127 S159-S166... [Pg.128]

Fig. 3.3.1. This flowchart illustrates the algorithm used for selecting the appropriate treatment option for patients with hepatocellular carcinoma (HCC) including surgical resection, transplantation, radiofrequency ablation RFA)y transarte-rial chemoembolization (TAC ), new agents such as selective internal radiation therapy (SIRT)y systemic therapy and best supportive care. RFA is offered to patients with early-stage HCC with a single tumor smaller than 5 cm or as many as three lesions, each smaller than 3 cm, good performance status and evidence for neither vascular invasion nor extrahepatic tumor spread based on clinical and imaging flndings. (M Metastases, N nodules, PEI percutaneous ethanol injection, PST performance status test.) "Cadaveric liver transplantation or living donor liver transplantation With permission from Llovet et al. (2003) Lancet 362 1907-1917... Fig. 3.3.1. This flowchart illustrates the algorithm used for selecting the appropriate treatment option for patients with hepatocellular carcinoma (HCC) including surgical resection, transplantation, radiofrequency ablation RFA)y transarte-rial chemoembolization (TAC ), new agents such as selective internal radiation therapy (SIRT)y systemic therapy and best supportive care. RFA is offered to patients with early-stage HCC with a single tumor smaller than 5 cm or as many as three lesions, each smaller than 3 cm, good performance status and evidence for neither vascular invasion nor extrahepatic tumor spread based on clinical and imaging flndings. (M Metastases, N nodules, PEI percutaneous ethanol injection, PST performance status test.) "Cadaveric liver transplantation or living donor liver transplantation With permission from Llovet et al. (2003) Lancet 362 1907-1917...
All of the percutaneous techniques are limited by the size and number of the lesions (up to three lesions each measuring up to 4 cm) as well as their location. Subdiaphragmatic lesions may be percutaneously inaccessible, and lesions close to large vascular structures respond poorly to thermal ablation techniques (RFA, MCT, Cryo, and LIPC). On the contrary, intra-arterial techniques are not limited by the number, size, or location of the lesions rather by the hepatic function reserve, as shown in Table 10.2. TACE, trans-arterial chemo-embolization TARE, trans-arterial radio-embolization MCT, microwave coagulation therapy RFA, radio frequency ablation LIPC, laser interstitial photocoagulation Cryo, cryo-ablation PEI, percutaneous ethanol injection PAAI, percutaneous acetic acid injection PCI, percutaneous chemotherapy injection... [Pg.130]

Livraghi T, Lazzaroni S, Pellicano S, et al (1993) Percutaneous ethanol injection of hepatic tumors single-session therapy with general anesthesia. AJR Am J Roentgenol 161 1065-1069... [Pg.360]

Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS. 2004. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 54 415 20. [Pg.290]

Transarterial chemoembolization (TACE) has widely been proposed as the palliative treatment of choice. However, most data indicate a limited benefit from TACE in patients with advanced liver cirrhosis (Llovet et al. 2003). In the past percutaneous tumor ablation by radiofrequency (RFA) or laser-induced thermo therapy (LITT) has supplemented ethanol injection. Any of these methods has hmitations with respect to tumor size, perfusion and localization, as described above. [Pg.67]

Kurokohchi K, Masaki T, Miyauchi Y et al (2004) Efficacy of combination therapies of percutaneous or laparoscopic ethanol-lipiodol injection and radiofrequency ablation. Int J Oncol 25 1737-1743... [Pg.138]

See other pages where Percutaneous ethanol injection therapy is mentioned: [Pg.1376]    [Pg.164]    [Pg.336]    [Pg.336]    [Pg.362]    [Pg.270]    [Pg.1376]    [Pg.164]    [Pg.336]    [Pg.336]    [Pg.362]    [Pg.270]    [Pg.1374]    [Pg.2413]    [Pg.290]    [Pg.193]    [Pg.98]    [Pg.120]    [Pg.120]    [Pg.121]    [Pg.164]    [Pg.241]    [Pg.242]    [Pg.125]   
See also in sourсe #XX -- [ Pg.275 , Pg.278 ]



SEARCH



Ethanol injection

Percutaneous

Percutaneous ethanol injection

© 2024 chempedia.info